Tag Archives: Percutaneous coronary intervention

Boston Scientific renews contract for clinical specialist training and CTO business program development

boston_squareOn the 1st of January J-Link and Boston Scientific agreed to extend their cooperation for the interventional cardiology and peripheral field.

Boston Scientific is a leading innovator of medical solutions that improve the health of patients around the world.

Approx. 24,000 employees worldwide
12 manufacturing facilities worldwide
Market presence in nearly 100 countries
$886 million invested in R&D
$7.25 billion revenue

J-Link is offering consultancy services for developing clinical training programmes for both sales staff as well as physicians, assisting with proctorships, on-site clinical assistance, consultancy on business development for the BridgePoint medical devices and development of the field of CTO treatment in interventional cardiology.

J-Link will visit Bio Japan and CCT congresses

logo_biojapan2013

On October 9th J-Link will visit Bio Japan congress in Yokohama, Japan. Bio Japan is Asia’s Premier Partnering Event for the Global Biotechnology Industry. It has played an important role in facilitating interaction between Japanese and global companies/organizations and stimulating new business opportunities. The Japanese and global biotechnology industry’s top business development and licensing professionals, alliance management professionals, R&D personnel and biotech company executives will gather in Yokohama for Bio Japan.
logo_cct2013

On the 17th of October Complex Cardiovascular Therapeutics (CCT) congress will be held in Kobe, Japan. CCT 2013 will provide the highest quality of cardiovascular care, either percutaneous transcatheter or surgical, for the patients with coronary, structural, heart diseases and peripheral vascular diseases. It is the congress’ mission that has always emphasized and focused on advancement and refinement of the technical approaches and skills for a higher success rate and safer procedures to treat complex, difficult and most challenging cases in Cardiovascular and Peripheral fields. J-Link will participate in this congress to get insight and information on cutting edge technologies that will change interventional cardiology and peripheral procedures in the future.

 

 

J-Link closes clinical training and CTO business program development contract with Boston Scientifc

boston_squareOn the 1st of August J-Link and Boston Scientific agreed on a business development contract for the interventional cardiology and peripheral field.

Boston Scientific is a leading innovator of medical solutions that improve the health of patients around the world.

Approx. 24,000 employees worldwide
12 manufacturing facilities worldwide
Market presence in nearly 100 countries
$886 million invested in R&D
$7.25 billion revenue

J-Link is offering consultancy services for developing clinical training programmes for both sales staff as well as physicians, assisting with proctorships, on-site clinical assistance, consultancy on business development for the BridgePoint medical devices and development of the field of CTO treatment in interventional cardiology.